Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
20
×
life sciences
20
×
national blog main
boston blog main
san francisco blog main
boston top stories
clinical trials
national top stories
startups
new york blog main
new york top stories
san francisco top stories
deals
fda
national
san diego blog main
san diego top stories
boston
investing
raleigh-durham blog main
raleigh-durham top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
medical device
pfizer
seattle blog main
seattle top stories
springworks therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acute myeloid leukemia
What
biotech
20
×
new
drug
ipo
life
medicines
research
companies
raised
days
medical
million
roundup
therapeutics
based
bio
cancer
leading
medicine
public
science
sciences
startup
week
american
annual
attention
company
control
developing
diseases
drugs
future
genetic
genomics
hasn’t
industry
innovation
investment
investors
Language
unset
Current search:
biotech
×
" life sciences "
×
biotech
×
@tech.eu
2 years ago
Why biotech investors are attracted to Lithuania
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@techcrunch.com
4 years ago
UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@techcrunch.com
5 years ago
China is funding the future of American biotech
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More